These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30183777)

  • 41. Human coronavirus NL63 in children: epidemiology, disease spectrum, and genetic diversity.
    Leung TF; Chan PK; Wong WK; Ip M; Cheng WT; Ng PC
    Hong Kong Med J; 2012 Feb; 18 Suppl 2():27-30. PubMed ID: 22311358
    [TBL] [Abstract][Full Text] [Related]  

  • 42. His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display.
    Koho T; Ihalainen TO; Stark M; Uusi-Kerttula H; Wieneke R; Rahikainen R; Blazevic V; Marjomäki V; Tampé R; Kulomaa MS; Hytönen VP
    Eur J Pharm Biopharm; 2015 Oct; 96():22-31. PubMed ID: 26170162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification of virus-like particles (VLPs) expressed in the silkworm Bombyx mori.
    Minkner R; Park EY
    Biotechnol Lett; 2018 Apr; 40(4):659-666. PubMed ID: 29383470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human coronavirus NL63, France.
    Vabret A; Mourez T; Dina J; van der Hoek L; Gouarin S; Petitjean J; Brouard J; Freymuth F
    Emerg Infect Dis; 2005 Aug; 11(8):1225-9. PubMed ID: 16102311
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome structure and transcriptional regulation of human coronavirus NL63.
    Pyrc K; Jebbink MF; Berkhout B; van der Hoek L
    Virol J; 2004 Nov; 1():7. PubMed ID: 15548333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of recombinant protein shells of Johnson grass chlorotic stripe mosaic virus in tobacco plants and their use as drug carrier.
    Alemzadeh E; Izadpanah K; Ahmadi F
    J Virol Methods; 2017 Oct; 248():148-153. PubMed ID: 28709614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of Virus-Like Particles for Vaccination.
    Thompson CM; Aucoin MG; Kamen AA
    Methods Mol Biol; 2016; 1350():299-315. PubMed ID: 26820864
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of human enterovirus71 virus-like particles used for vaccine antigens.
    Zhao D; Sun B; Sun S; Fu B; Liu C; Liu D; Chu Y; Ma Y; Bai L; Wu Y; Zhou Y; Su W; Hou A; Cai L; Xu F; Kong W; Jiang C
    PLoS One; 2017; 12(7):e0181182. PubMed ID: 28732070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronavirus HKU1 and other coronavirus infections in Hong Kong.
    Lau SK; Woo PC; Yip CC; Tse H; Tsoi HW; Cheng VC; Lee P; Tang BS; Cheung CH; Lee RA; So LY; Lau YL; Chan KH; Yuen KY
    J Clin Microbiol; 2006 Jun; 44(6):2063-71. PubMed ID: 16757599
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Melting Curve-Based Multiplex RT-qPCR Assay for Simultaneous Detection of Four Human Coronaviruses.
    Wan Z; Zhang Y; He Z; Liu J; Lan K; Hu Y; Zhang C
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New generation of viral nanoparticles for targeted drug delivery in cancer therapy.
    Alvandi N; Rajabnejad M; Taghvaei Z; Esfandiari N
    J Drug Target; 2022 Feb; 30(2):151-165. PubMed ID: 34210232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virus-like particle-based nanocarriers as an emerging platform for drug delivery.
    Yuan B; Liu Y; Lv M; Sui Y; Hou S; Yang T; Belhadj Z; Zhou Y; Chang N; Ren Y; Sun C
    J Drug Target; 2023 Jun; 31(5):433-455. PubMed ID: 36940208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Virus-like particles for drug delivery: a review of methods and applications.
    Ikwuagwu B; Tullman-Ercek D
    Curr Opin Biotechnol; 2022 Dec; 78():102785. PubMed ID: 36099859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a novel platform of virus-like particle (VLP)-based vaccine against COVID-19 by exposing epitopes: an immunoinformatics approach.
    Ghorbani A; Zare F; Sazegari S; Afsharifar A; Eskandari MH; Pormohammad A
    New Microbes New Infect; 2020 Nov; 38():100786. PubMed ID: 33072338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System.
    Xu R; Shi M; Li J; Song P; Li N
    Front Bioeng Biotechnol; 2020; 8():862. PubMed ID: 32850726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice.
    Lu J; Lu G; Tan S; Xia J; Xiong H; Yu X; Qi Q; Yu X; Li L; Yu H; Xia N; Zhang T; Xu Y; Lin J
    Cell Res; 2020 Oct; 30(10):936-939. PubMed ID: 32801356
    [No Abstract]   [Full Text] [Related]  

  • 58. Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells.
    Kato T; Takami Y; Kumar Deo V; Park EY
    J Biotechnol; 2019 Dec; 306():177-184. PubMed ID: 31614169
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Replication of Severe Acute Respiratory Syndrome Coronavirus 2 in Human Respiratory Epithelium.
    Milewska A; Kula-Pacurar A; Wadas J; Suder A; Szczepanski A; Dabrowska A; Owczarek K; Marcello A; Ochman M; Stacel T; Rajfur Z; Sanak M; Labaj P; Branicki W; Pyrc K
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32434888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63.
    Weng JR; Lin CS; Lai HC; Lin YP; Wang CY; Tsai YC; Wu KC; Huang SH; Lin CW
    Virus Res; 2019 Nov; 273():197767. PubMed ID: 31560964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.